Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AmpliTech (AMPG) Accounts Payables (2016 - 2025)

AmpliTech (AMPG) has disclosed Accounts Payables for 11 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 394.3% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, up 394.3% year-over-year, with the annual reading at $4.7 million for FY2025, 394.3% up from the prior year.
  • Accounts Payables for Q4 2025 was $4.7 million at AmpliTech, up from $4.0 million in the prior quarter.
  • The five-year high for Accounts Payables was $5.4 million in Q2 2025, with the low at $348438.0 in Q1 2021.
  • Average Accounts Payables over 5 years is $1.8 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Accounts Payables surged 2547.8% in 2021, then crashed 71.38% in 2022.
  • Over 5 years, Accounts Payables stood at $3.0 million in 2021, then plummeted by 71.38% to $860366.0 in 2022, then dropped by 1.65% to $846179.0 in 2023, then grew by 11.25% to $941408.0 in 2024, then surged by 394.3% to $4.7 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $4.7 million, $4.0 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.